In line with mitotic kinesins being strategic targets for amplifying CIN to lethal levels, Tucker et al. recently demonstrated that CENPE inhibition enhanced CIN and synergized with microtubule-disrupting agents in breast cancer [133]. The gene discussed is CENPE; the disease is breast cancer.